We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$249M
AUM Growth
+$11.2M
Cap. Flow
+$1.58M
Cap. Flow %
0.64%
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$7.05M
2
AMZN icon
Amazon
AMZN
+$3.89M
3
QURE icon
uniQure
QURE
+$2.86M
4
BNTX icon
BioNTech
BNTX
+$2.81M
5
DXCM icon
DexCom
DXCM
+$2.78M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.6M
2
PG icon
Procter & Gamble
PG
+$3.27M
3
NVO
Novo Nordisk
NVO
+$3.16M
4
CVS icon
CVS Health
CVS
+$3.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.85M

Sector Composition

Rank Sector Weight
1 Technology 35.23%
2 Healthcare 25.2%
3 Consumer Discretionary 20.47%
4 Communication Services 8.05%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLMD icon
451
Relmada Therapeutics
RLMD
$503M
-282
Closed -$10K
RLYB icon
452
Rallybio
RLYB
$88.1M
-38
Closed -$4K
RPID icon
453
Rapid Micro Biosystems
RPID
$84.8M
-341
Closed -$1K
SABS icon
454
SAB Biotherapeutics
SABS
$346M
-40
Closed
SEER icon
455
Seer Inc
SEER
$118M
-548
Closed -$4K
SERA icon
456
Sera Prognostics
SERA
$79.1M
-277
Closed
SLDB icon
457
Solid Biosciences
SLDB
$971M
-71
Closed
FTH
458
Faeth Therapeutics
FTH
$757M
-14
Closed
SPRO icon
459
Spero Therapeutics
SPRO
$68.9M
-329
Closed -$1K
STM icon
460
STMicroelectronics
STM
$48.4B
-32,000
Closed -$990K
STTK icon
461
Shattuck Labs
STTK
$752M
-397
Closed -$1K
SYRE icon
462
Spyre Therapeutics
SYRE
$9.18B
-23
Closed
TKNO icon
463
Alpha Teknova
TKNO
$397M
-263
Closed -$1K
TNK icon
464
Teekay Tankers
TNK
$2.81B
-24,900
Closed -$686K
TNXP icon
465
Tonix Pharmaceuticals
TNXP
$205M
0
TNYA icon
466
Tenaya Therapeutics
TNYA
$171M
-387
Closed -$1K
TRML
467
DELISTED
Tourmaline Bio
TRML
-39
Closed -$1K
TSHA icon
468
Taysha Gene Therapies
TSHA
$2.05B
-385
Closed -$1K
VOR icon
469
Vor Biopharma
VOR
$1.21B
-18
Closed -$1K
VRCA icon
470
Verrica Pharmaceuticals
VRCA
$87.4M
-39
Closed -$1K
VSTM icon
471
Verastem
VSTM
$629M
-147
Closed -$1K
XLP icon
472
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
-9,750
Closed -$651K
XLY icon
473
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
-1,800
Closed -$128K
YMAB
474
DELISTED
Y-mAbs Therapeutics
YMAB
-410
Closed -$6K
ZVRA icon
475
Zevra Therapeutics
ZVRA
$679M
-323
Closed -$2K

Similar funds

China Universal Asset Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
  • China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
  • China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
  • China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
  • China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
  • China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.